Lupi Monica相关文献与解析，生知库 | 链接生命科学的每一步

Wainer-Katsir Kerem, Haber Adi, Fishman Hila, Ding Lianghao, Story Michael D, Du Renfei, Kahlert Ulf D, Mannarino Laura, Mirimao Federica, Lupi Monica, D'Incalci Maurizio, Lavy-Shahaf Gitit, Ene Hila, Frechtel-Gerzi Roni, Drawshy Zeina, Martinez-Conde Antonia, Dor-On Eyal, Porat Yaara, Giladi Moshe, Weinberg Uri, Palti Yoram

肿瘤

发表日期：2025

文献求助收藏

Selective antitumor activity of Tumor Treating Fields (TTFields) involving molecular factors in cancer cells and tumor microenvironment

肿瘤电场疗法（TTFields）通过作用于癌细胞和肿瘤微环境中的分子因子发挥选择性抗肿瘤活性

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2025.102556

Fuso Nerini, Ilaria; Amodeo, Rosy; D'Incalci, Maurizio; Lupi, Monica

Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging

利用多模态成像技术分析新型聚（ADP-核糖）聚合酶（PARP）抑制剂帕米帕利在肿瘤组织中的分布

期刊:

影响因子:

doi:10.1016/j.jpha.2024.101079

Morosi, Lavinia; Timo, Sara; Amodeo, Rosy; Lupi, Monica; Meroni, Marina; Bello, Ezia; Frapolli, Roberta; Martano, Giuseppe; D'Incalci, Maurizio

Local Health Department Values and Organizational Authorities Guiding Cross-Sector Work During COVID-19

地方卫生部门的价值观和组织权限指导新冠疫情期间的跨部门合作

期刊:

影响因子:

doi:10.1177/15248399231192989

Johnson, Karl; Biddell, Caitlin B; Gora Combs, Katherine; Wiesman, John; Valdes Lupi, Monica; Hassmiller Lich, Kristen

Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia

更正：S100A3 是一种伴侣蛋白，在乳腺癌/肺癌和急性髓系白血病的细胞模型中调节 RARα 和 PML-RARα 的稳定性/活性。

期刊:Oncogene

影响因子:7.3

doi:10.1038/s41388-022-02564-8

Gianni, Maurizio; Terao, Mineko; Kurosaki, Mami; Paroni, Gabriela; Brunelli, Laura; Pastorelli, Roberta; Zanetti, Adriana; Lupi, Monica; Acquavita, Andrea; Bolis, Marco; Fratelli, Maddalena; Rochette-Egly, Cecile; Garattini, Enrico

Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

线粒体和心磷脂在视黄酸抑制乳腺癌细胞生长中的作用

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-019-1438-y

Terao, Mineko; Goracci, Laura; Celestini, Valentina; Kurosaki, Mami; Bolis, Marco; Di Veroli, Alessandra; Vallerga, Arianna; Fratelli, Maddalena; Lupi, Monica; Corbelli, Alessandro; Fiordaliso, Fabio; Gianni, Maurizio; Paroni, Gabriela; Zanetti, Adriana; Cruciani, Gabriele; Garattini, Enrico

Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

更正：线粒体和心磷脂在视黄酸抑制乳腺癌细胞生长中的作用

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-019-1485-4

S100A3 a partner protein regulating the stability/activity of RARÎ± and PML-RARÎ± in cellular models of breast/lung cancer and acute myeloid leukemia.

S100A3 是一种伴侣蛋白，可调节乳腺癌/肺癌和急性髓系白血病细胞模型中 RARÎ± 和 PML-RARÎ± 的稳定性/活性

期刊:Oncogene

影响因子:7.3

doi:10.1038/s41388-018-0599-z

Gianni Maurizio, Terao Mineko, Kurosaki Mami, Paroni Gabriela, Brunelli Laura, Pastorelli Roberta, Zanetti Adriana, Lupi Monica, Acquavita Andrea, Bolis Marco, Fratelli Maddalena, Rochette-Egly Cecile, Garattini Enrico

No Equity, No Triple Aim: Strategic Proposals to Advance Health Equity in a Volatile Policy Environment

没有公平，就没有三重目标：在动荡的政策环境下推进健康公平的战略建议

期刊:American Journal of Public Health

影响因子:9.6

doi:10.2105/AJPH.2017.304000

Wilkinson, Geoffrey W; Sager, Alan; Selig, Sara; Antonelli, Richard; Morton, Samantha; Hirsch, Gail; Lee, Celeste Reid; Ortiz, Abigail; Fox, Durrell; Lupi, Monica Valdes; Acuff, Cecilia; Wachman, Madeline

发表日期：2017

文献求助收藏

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells

KRAS(G12C)突变型非小细胞肺癌细胞中碱基切除修复介导的顺铂耐药性

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.5019

Caiola, Elisa; Salles, Daniela; Frapolli, Roberta; Lupi, Monica; Rotella, Giuseppe; Ronchi, Anna; Garassino, Marina Chiara; Mattschas, Nikola; Colavecchio, Stefano; Broggini, Massimo; Wiesmüller, Lisa; Marabese, Mirko

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

肿瘤电场治疗（TTFields）对癌症反应的转录组学特征

Selective antitumor activity of Tumor Treating Fields (TTFields) involving molecular factors in cancer cells and tumor microenvironment

肿瘤电场疗法（TTFields）通过作用于癌细胞和肿瘤微环境中的分子因子发挥选择性抗肿瘤活性

Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging

利用多模态成像技术分析新型聚（ADP-核糖）聚合酶（PARP）抑制剂帕米帕利在肿瘤组织中的分布

Local Health Department Values and Organizational Authorities Guiding Cross-Sector Work During COVID-19

地方卫生部门的价值观和组织权限指导新冠疫情期间的跨部门合作

Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia

更正：S100A3 是一种伴侣蛋白，在乳腺癌/肺癌和急性髓系白血病的细胞模型中调节 RARα 和 PML-RARα 的稳定性/活性。

Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

线粒体和心磷脂在视黄酸抑制乳腺癌细胞生长中的作用

Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

更正：线粒体和心磷脂在视黄酸抑制乳腺癌细胞生长中的作用

S100A3 a partner protein regulating the stability/activity of RARÎ± and PML-RARÎ± in cellular models of breast/lung cancer and acute myeloid leukemia.

S100A3 是一种伴侣蛋白，可调节乳腺癌/肺癌和急性髓系白血病细胞模型中 RARÎ± 和 PML-RARÎ± 的稳定性/活性

No Equity, No Triple Aim: Strategic Proposals to Advance Health Equity in a Volatile Policy Environment

没有公平，就没有三重目标：在动荡的政策环境下推进健康公平的战略建议

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells

KRAS(G12C)突变型非小细胞肺癌细胞中碱基切除修复介导的顺铂耐药性